Atlas Trials

Safety and Efficacy Study of YZJ-1139 in Primary Chronic Insomnia Disorder

Clinical trial NCT06680505 · COMPLETED

Trial details

NCT number
NCT06680505
Sponsor
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Insomnia Disorder
Start date
2019-08-04
Primary completion
2020-09-30
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.